Global Amniocentesis Needles Market - 2022-2029

Market Overview

The global amniocentesis needles market size was valued at US$ XX million in 2022 and is estimated to reach US$ XX million by 2029, growing at a CAGR of 4.2% during the forecast period (2022-2029).

The amniocentesis needles are utilized for the amniocentesis procedure in which amniotic fluid or cells are removed for testing and treatment from the uterus. The baby is surrounded and protected by amniotic fluid during the pregnancy. Information regarding the baby's health can be determined via amniocentesis.

Market Dynamics

The major factors driving the global amniocentesis needles market are an increase in the number of childbirths across the globe and awareness among the population regarding fatal genetic disorders such as down's syndrome or infections. An increase in novel product launches contributes to the growth of the amniocentesis needles market.

The increasing number of childbirths and increasing adoption of amniocentesis procedures are expected to drive the market's growth.

The rising adoption of amniocentesis procedures for genetic disorders, fetal lung testing and infection diagnosis, an increase in pregnancies, and the rising number of novel product launches drive the amniocentesis needles market. An increase in the number of childbirths is also aiding the market growth. There has been an increase in R&D activities by many healthcare companies to develop novel products.

Amniocentesis needles are used in various applications such as genetic testing, fetal blood transfusion, fetal lung testing, amnioreduction procedure, polyhydramnios treatment, percutaneous umbilical cord sampling, and fetal infection diagnosis. The market for these applications is increasing worldwide due to the increasing number of infant genetic disorders. Moreover, the availability of technologically advanced products by key players is also expected to play a vital role in the market's growth.

Various novel product launches and research studies contribute to the market's growth. For instance, in January 5, 2021, Cooper Surgical, a women's healthcare solution provider, announced its acquisition of Embryo Options, a cryo-storage solutions provider. This acquisition enhances Cooper's innovative fertility product portfolio.

The risks associated with these devices and the high cost are expected to hamper the market's growth.

However, there are several risks faced by the minor population, such as leakage of amniotic fluid in which, after amniocentesis small amount of amniotic fluid starts leaking through the vagina. This is rare and doesn't affect pregnancy. Needle injury is another risk where the baby might bring its leg or arm in the path of the needle that, causes injury.

During the second trimester, there is a little risk of miscarriage in the amniocentesis procedure if done by an experienced person with the help of ultrasound. It can trigger a urine infection. Rh sensitization is also a complication when a baby's blood cells enter the mother's bloodstream. Rh-negative mother is given Rh immunoglobulin injection to prevent the mother's body from making Rh antibodies that can cause damage to the blood cells of the baby.

COVID-19 Impact Analysis

The pandemic has negatively impacted global financial expectations, operations and crisis response strategy. The COVID-19 outbreak has severely impacted the healthcare industry. The amniocentesis needles market has experienced huge losses due to COVID, as various research and clinical trials started in full swing due to the increasing cases of COVID. Various initiatives, product launches, innovations, collaborations and mergers are happening worldwide, boosting the market's growth. For instance, in Apr 2021, Medax SRL announced the commercialization of MedOne Ultra and MedEasy in India.

Segment Analysis

The amniocentesis segment is expected to grow at the fastest CAGR during the forecast period (2022-2029)

The amniocentesis segment is the largest market shareholder due to its high demand, increasing childbirth and rising adoption of amniocentesis procedures.

A prenatal test named amniocentesis is done for genetic disorders diagnosis. Genetic disorders, including spina bifida and down syndrome and other fetus health issues. Amniocentesis needles are used for amniotic fluid removal in a small amount from the uterus. The lab then tests the amniotic fluid sample for various genetic or chromosomal conditions. This procedure is done during the second or third trimester of pregnancy.

The growing number of regulatory approvals, technological advancements, product launches, and research/clinical trial studies drive the market's growth. For instance, MRD SRL's Amnio needle is a novel stainless steel cannula needle that is disposable and is used for amniotic fluid transabdominal sampling for prenatal diagnosis of the fetus, such as genetic disorders known as amniocentesis. This needle has an echogenic marker that supports correct needle placement in ultrasound guidance. Adjustable stoppers and centimeter markings help to determine the insertion depth.

Geographical Analysis

North America holds the largest market share in the global amniocentesis needles market.

North America dominates the global amniocentesis needles market, primarily due to its large population combined with excellent medical infrastructure and the rising number of childbirth and pregnancies. According to National Centre for Health, in 2022, cancer was the second leading cause of mortality worldwide, with around 1,918,030 new cases registered 2022. Cancer was responsible for 609,360 deaths all over the world. Moreover, as per WHO, the number of new cases is expected to rise by around 70% by 2030.

Increasing expenditure on healthcare and raising awareness among people is also contributing to the market's growth in this region. Advancement of applications of amniocentesis needles in amniocentesis procedures and prenatal diagnostics, such as genetic disorders and fatal infections, increase in pharmaceutical establishment across the region and government approvals, and the presence of key players in the region are contributing to the growth of the amniocentesis needles market.

Moreover, the growing number of product launches is responsible for the market's growth. Many key developments, technological advancements, collaborations, and agreements are taking place in this region. For instance, in Jan 6, 2022, ICU Medical Inc., announced it had completely acquired Smiths Medical from the Smith's Group. Smith's Medical business such as syringes, vital care and vascular access products, and ambulatory infusion devices.

Competitive Landscape

The amniocentesis needles market is moderately competitive with local and global companies' presence. Cooper Surgical Inc., Cook, ICU Medical Inc., Biopsybell, Becton, Dickinson and Company, Medline Industries LP, RI. MOS. Srl, Laboratoire CCD, Rocket Medical Plc, Medax Srl and more. The key players are adopting various growth strategies such as product launches, mergers & acquisitions, partnerships, and collaborations, contributing to the market's growth. For instance, in Dec 17, 2021, Cooper Companies announced its completion of an acquisition agreement with Generate Life Sciences, a donor egg and sperm provider for fertility treatment and stem cell storage of newborns (cord tissue and blood).

Cooper Surgical Inc.

Overview: Cooper Surgical is a medical device company that focuses on women's and babies' health advancements with its wide products and services portfolio on fertility and genomics, and medical devices. It was established in 1990 and is headquartered in Connecticut, United States.

Product Portfolio:

Wallace Amniocentesis Needles: Wallace is an amniocentesis single-use needle that is provided in sterile packs for the sampling of amniotic fluid. The tip of the needle contains spiral engraving that offers clear visibility.

The global amniocentesis needles market report would provide access to approx. 45 + market data tables, 40 + figures and 200 (approximate) pages.